Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LANCL2 | Q9NS86 | 1/20 | 0.62 |
| ▸ | ATR | Q13535 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | METAP2 | P50579 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.52 |
| ▸ | METAP1 | P53582 | 1/20 | 0.52 |
| ▸ | HTR2B | P41595 | 3/20 | 0.52 |
| ▸ | SPR | P35270 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17706589 | 0.84 | KDM4E (0.70) | LANCL2ATRHPGDNPC1RAB9A | |
| SCHEMBL21043481 | 0.80 | LANCL2 (0.66) | LANCL2ATRHPGDNPC1RAB9A | |
| SCHEMBL20762507 | 0.80 | NPC1 (0.63) | HPGDMETAP2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL21705044 | 0.80 | LANCL2 (0.79) | LANCL2ATRHPGDNPC1RAB9A | |
| Omilancor SCHEMBL17706588 | 0.77 | LANCL2 (1.00) | LANCL2ATRHPGDMETAP2NPC1 | |
| Omilancor SCHEMBL29349469 | 0.77 | LANCL2 (1.00) | LANCL2ATRHPGDMETAP2NPC1 | |
| SCHEMBL25310542 | 0.76 | LANCL2 (0.76) | LANCL2ATRHPGDNPC1RAB9A | |
| SCHEMBL12833993 | 0.76 | MEN1 (0.66) | LANCL2ATRHPGDSMN1; SMN2MTOR | |
| SCHEMBL2952771 | 0.76 | NPC1 (0.64) | HPGDMETAP2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30988885 | 0.76 | NPC1 (0.64) | HPGDMETAP2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11197891-B2 | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith | LANDOS BIOPHARMA, INC. (US) | 2021-12-14 | — | — | US | disclosed |
| US-20190160100-A1 | THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH | LANDOS BIOPHARMA, INC. (US) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190160100-A1 | THERAPIES WITH LANTHIONINE C-LIKE PROTEIN 2 LIGANDS AND CELLS PREPARED THEREWITH | LCP2, LANCL2, CALCB | LANCL2 2/4885ATR 4863/4885HPGD 3981/4885 |
| US-11197891-B2 | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith | LCP2, LANCL2, CALCB | LANCL2 2/4885ATR 4863/4885HPGD 3981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.